Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort

Journal of Internal Medicine

Volumn 251, Issue 2, 2002, Pages 102-110

  Karvonen, J ^a   Kauma, H ^a   Kervinen, K ^a   Rantala, M ^a   Ikaheimo M ^a   Paivansalo M ^a   Savolainen, M J ^a   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Atherosclerosis; Genetics; Hypertension; Nitric oxide

Indexed keywords

ANTIHYPERTENSIVE AGENT; NITRIC OXIDE SYNTHASE;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; ECHOGRAPHY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; FINLAND; GENE; GENOTYPE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PUBLIC HEALTH; RADIODIAGNOSIS; RISK FACTOR; SCREENING; STRATIFICATION;

ALLELES; ASPARTIC ACID; BLOOD PRESSURE; CAROTID STENOSIS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FINLAND; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; GLUTAMIC ACID; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYMORPHISM, GENETIC; RISK;

EID: 0036169224     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00933.x     Document Type: Article

References (40)

1. The L-arginine-nitric oxide pathway
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
3. Release of norepinephrine from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor
4. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide
5. Endothelium-derived relaxing factor inhibits renin release
6. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
7. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
8. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro
9. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
10. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells
11. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis
12. Endothelial dysfunction and atherosclerosis
13. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
14. 2 does not contribute to impaired endothelium-dependent relaxation
15. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
16. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase
17. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice
18. Polymorphisms of the endothelial nitric oxide synthase gene - No consistent association with myocardial infarction in the ECTIM study
19. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298
20. Endothelial nitric oxide synthase gene is positively associated with essential hypertension
21. Association of the missense Glu298Asp variant of eNOS gene with left ventricular hypertrophy and carotid atherosclerosis in patients with essential hypertension
22. 298 → Asp) is a major risk factor for coronary artery disease in the UK
23. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction
24. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction
25. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese
26. NOS3 Glu298Asp genotype and blood pressure response to endurance training: The heritage family study
27. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure
28. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects
29. Variants of renin-angiotensin system genes and echocardiographic left ventricular mass
30. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound
31. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothe-lial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus
32. -298 → Asp (894G → T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease
33. Coronary artery disease is not associated with the E298 → D variant of the constitutive, endothelial nitric oxide synthase gene
34. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population
35. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene
36. -786 →C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm
37. -786 →C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility
38. Ultrasound measurement of wall thickness in the carotid artery: Fundamental principles and description of a computerized analyzing system
39. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase